John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$172M |
| 2 |
Johnson & Johnson
JNJ
|
+$161M |
| 3 |
American Express
AXP
|
+$161M |
| 4 |
Apple
AAPL
|
+$156M |
| 5 |
Emerson Electric
EMR
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$172M |
| 2 |
AGN
Allergan Inc
AGN
|
+$139M |
| 3 |
Wynn Resorts
WYNN
|
+$111M |
| 4 |
AbbVie
ABBV
|
+$94.4M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$94.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 14.92% |
| 2 | Technology | 11.5% |
| 3 | Industrials | 10.9% |
| 4 | Healthcare | 10.87% |
| 5 | Consumer Staples | 7.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TWX
1876
PUT
DELISTED
Time Warner Inc
TWX
| $591K | ﹤0.01% |
+7,000
| New | +$582K |
|
1877
Wells Fargo
WFC
$256B
| $590K | ﹤0.01% |
10,850
-1,695,776
| -99% | -$91.6M |
|
1878
NACCO Industries
NC
$309M
| $588K | ﹤0.01% |
48,607
-25,338
| -34% | -$324K |
|
1879
CALL
McDonald's
MCD
$193B
| $585K | ﹤0.01% |
+6,000
| New | +$569K |
|
|
PHIIK
1880
DELISTED
PHI, Inc. Non-Voting Common Stock
PHIIK
| $585K | ﹤0.01% |
19,436
+6,118
| +46% | +$204K |
|
|
AUD
1881
DELISTED
Audacy, Inc.
AUD
| $584K | ﹤0.01% |
48,041
+26,100
| +119% | +$312K |
|
1882
KVH Industries
KVHI
$136M
| $582K | ﹤0.01% |
+38,507
| New | +$502K |
|
1883
Exponent
EXPO
$3.37B
| $581K | ﹤0.01% |
+26,164
| New | +$560K |
|
1884
PUT
The Greenbrier Companies
GBX
$1.43B
| $580K | ﹤0.01% |
+10,000
| New | +$553K |
|
1885
Tempest Therapeutics
TPST
$17.6M
| $579K | ﹤0.01% |
+6
| New | +$799K |
|
|
IXYS
1886
DELISTED
IXYS Corp
IXYS
| $579K | ﹤0.01% |
46,998
-2,138
| -4% | -$25.6K |
|
1887
Oracle
ORCL
$410B
| $578K | ﹤0.01% |
13,390
-167,592
| -93% | -$7.26M |
|
|
ACAT
1888
DELISTED
Arctic Cat Inc
ACAT
| $577K | ﹤0.01% |
15,881
+2,183
| +16% | +$78.6K |
|
|
AMRN
1889
Amarin Corp
AMRN
$292M
| $575K | ﹤0.01% |
+12,293
| New | +$375K |
|
|
HI
1890
DELISTED
Hillenbrand
HI
| $575K | ﹤0.01% |
+18,626
| New | +$585K |
|
1891
Orthofix Medical
OFIX
$399M
| $574K | ﹤0.01% |
15,990
-45,255
| -74% | -$1.42M |
|
1892
CALL
Ecolab
ECL
$80.4B
| $572K | ﹤0.01% |
+5,000
| New | +$548K |
|
1893
Biglari Holdings Class B
BH
$1.2B
| $571K | ﹤0.01% |
+2,067
| New | +$580K |
|
1894
EXL Service
EXLS
$5.71B
| $571K | ﹤0.01% |
76,795
-109,255
| -59% | -$715K |
|
1895
iShares Russell Mid-Cap ETF
IWR
$57.5B
| $571K | ﹤0.01% |
+13,200
| New | +$561K |
|
1896
Winmark
WINA
$1.26B
| $571K | ﹤0.01% |
+6,522
| New | +$535K |
|
|
K
1897
DELISTED
Kellanova
K
| $567K | ﹤0.01% |
+9,164
| New | +$560K |
|
1898
PUT
T. Rowe Price
TROW
$24B
| $567K | ﹤0.01% |
+7,000
| New | +$576K |
|
1899
Buckle
BKE
$2.29B
| $563K | ﹤0.01% |
+11,027
| New | +$555K |
|
|
LUMO
1900
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $563K | ﹤0.01% |
+1,143
| New | +$443K |
|
Similar funds
John Overdeck's Q1 2015 Portfolio in Review
As of Q1 2015, John Overdeck held 3,174 positions worth $21.5B, up 19% from $18.1B the previous quarter. Its ten largest holdings account for 7.3% of the portfolio.
John Overdeck deployed $3.03B of net new capital in Q1 2015, opening 981 new positions and adding to 805 existing holdings. Its largest new stake was Intel: 5,084,443 shares worth $159M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, up from 10% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was AbbVie, an estimated $94.4M trimmed.
- John Overdeck's largest Q1 2015 buy was Intel: 5,084,443 shares worth $159M.
- John Overdeck added most to Johnson & Johnson in Q1 2015, an estimated $161M increase.
- John Overdeck's biggest Q1 2015 reduction was AbbVie, cutting an estimated $94.4M.
- John Overdeck fully exited COVIDIEN PLC COM SHS NEW (IRELAND) in Q1 2015, selling an estimated $172M.
- John Overdeck's ten largest holdings make up 7.3% of its $21.5B portfolio in Q1 2015.
- John Overdeck opened 981 new positions and closed 576 in Q1 2015.
- John Overdeck's portfolio value rose 19% quarter-over-quarter to $21.5B.
Based on Two Sigma Investments's 13F filing for Q1 2015, filed 15 May 2015.